“…In particular, the primary advantages of ECG in COVID-19 include its ease in use, nominal labor intensiveness, minimal COVID-19 exposure risk, and wide availability and accessibility throughout hospitals, emergency departments, and outpatient clinics. Its short-term prognostic utility in COVID-19 has previously been described [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] ], further supporting its clinical application in this population. In light of an ongoing pandemic, we believe that the fundamental role of ECG extends beyond its diagnostic capacity to immediately detect time-sensitive conditions to include the powerful prediction of long-term mortality in patients with COVID-19.…”
Section: Discussionmentioning confidence: 64%
“…Owing to its widespread availability, ease of use, and minimal cost, one such tool that has been applied for this purpose is electrocardiography (ECG). Several studies have utilized ECG to identify untoward prognostic markers in COVID-19, which include atrial fibrillation (AF)/flutter [ [11] , [12] , [13] , [14] , [15] ], right-heart strain [ 13 , 16 ], intraventricular conduction abnormalities [ 11 , 12 , [17] , [18] , [19] ], ST segment abnormalities [ [12] , [13] , [14] ], and ischemic T-wave inversions [ 11 , 17 ]. However, these investigations often included only hospitalized patients and failed to prognosticate beyond in-hospital or 30-day outcomes.…”
Section: Introductionmentioning confidence: 99%
See 1 more Smart Citation
Kassis
1
,
Kumar
2
,
Gangidi
3
et al. 2022
Journal of Electrocardiology
No abstract
“…In particular, the primary advantages of ECG in COVID-19 include its ease in use, nominal labor intensiveness, minimal COVID-19 exposure risk, and wide availability and accessibility throughout hospitals, emergency departments, and outpatient clinics. Its short-term prognostic utility in COVID-19 has previously been described [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] ], further supporting its clinical application in this population. In light of an ongoing pandemic, we believe that the fundamental role of ECG extends beyond its diagnostic capacity to immediately detect time-sensitive conditions to include the powerful prediction of long-term mortality in patients with COVID-19.…”
Section: Discussionmentioning confidence: 64%
“…Owing to its widespread availability, ease of use, and minimal cost, one such tool that has been applied for this purpose is electrocardiography (ECG). Several studies have utilized ECG to identify untoward prognostic markers in COVID-19, which include atrial fibrillation (AF)/flutter [ [11] , [12] , [13] , [14] , [15] ], right-heart strain [ 13 , 16 ], intraventricular conduction abnormalities [ 11 , 12 , [17] , [18] , [19] ], ST segment abnormalities [ [12] , [13] , [14] ], and ischemic T-wave inversions [ 11 , 17 ]. However, these investigations often included only hospitalized patients and failed to prognosticate beyond in-hospital or 30-day outcomes.…”
Section: Introductionmentioning confidence: 99%
Kassis
1
,
Kumar
2
,
Gangidi
3
et al. 2022
Journal of Electrocardiology
No abstract
“…Table 1 describes the main characteristics of the 11 observational studies from the scoping review 11–20 . Seven studies (Antwi‐Amoabeng et al., Chen et al., Han et al., Kunal et al., Ray‐Acha et al., Wang et al., and Yang et al.)…”
Section: Resultsmentioning confidence: 99%
“…Table 1 describes the main characteristics of the 11 observational studies from the scoping review. 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 Seven studies (Antwi‐Amoabeng et al., Chen et al., Han et al., Kunal et al., Ray‐Acha et al., Wang et al., and Yang et al.) aimed to characterize electrocardiogram (EKG) findings among COVID‐19 patients without a particular focus on bradycardia.…”
Section: Resultsmentioning confidence: 99%
Nagamine
1
,
Randhawa
2
,
Nishimura
3
et al. 2022
Pacing Clinical Electrophis
COVID-19 has recently been associated with the development of bradyarrhythmias, although its mechanism is still unclear. We aim to summarize the existing evidence regarding bradyarrhythmia in COVID-19 and provide future directions for research.Following the PRISMA Extension for Scoping Reviews, we searched MEDLINE and EMBASE for all peer-reviewed articles using keywords including"Bradycardia," "atrioventricular block," and "COVID-19″ from their inception to October 13, 2021. Fortythree articles, including 11 observational studies and 59 cases from case reports and series, were included in the systematic review. Although some observational studies reported increased mortality in those with bradyarrhythmia and COVID-19, the lack of comparative groups and small sample sizes hinder the ability to draw definitive conclusions. Among 59 COVID-19 patients with bradycardia from case reports and series, bradycardia most often occurred in those with severe or critical COVID-19, and complete heart block occurred in the majority of cases despite preserved LVEF (55.9%).Pacemaker insertion was required in 76.3% of the patients, most of which were permanent implants (45.8%). This systematic review summarizes the current evidence and characteristics of bradyarrhythmia in patients with COVID-19. Further studies are critical to assess the reversibility of bradyarrhythmia in COVID-19 patients and to clarify potential therapeutic targets including the need for permanent pacing.
“…In a retrospective study to highlight the prognostic significance of ECG in COVID, Yang et al have compared the ECG changes in survivors and nonsurvivors. 30 It was observed that the nonsurvivors had significantly higher rates of prolonged QTc interval, axis deviation, arrhythmias, ST-T changes, and an overall higher abnormal ECG score. In our study population, QTc prolongation and tachycardia were the commonest changes in the deceased.…”
Section: Discussionmentioning confidence: 96%
Deepalakshmi
1
,
Kumar
2
,
Ramaraju
3
et al. 2022
Indian Journal of Critical Care Medicine
A bstract Background Coronavirus disease-2019 (COVID-19) infection is a multisystem disease not restricted to the lungs. It has a negative impact on the cardiovascular system by causing myocardial damage, vascular inflammation, plaque instability, and myocardial infarction. The presence of myocardial injury is a poor prognostic sign. Electrocardiogram (ECG), a simple bedside diagnostic test with high prognostic value, can be employed to assess early cardiovascular involvement in such patients. Various abnormalities in ECG like ST-T changes, arrhythmia, and conduction defects have been reported in COVID-19. We aimed to find out the ECG abnormalities of COVID-19 patients. Methods We performed a cross-sectional, hospital-based descriptive study among 315 COVID-19 in-patients who underwent ECG recording on admission. Patients’ clinical profiles were noted from their records, and the ECG abnormalities were studied. Results Among the abnormal ECGs 255 (81%), rhythm abnormalities were seen in 9 patients (2.9%), rate abnormalities in 115 patients (36.5%), and prolonged PR interval in 2.9%. Short QRS complex was seen in 8.3%. QT interval was prolonged in 8.3% of the patients. Significant changes in the ST and T segments (42.9%) were observed. In logistic regression analysis, ischemic changes in ECG were associated with systemic hypertension and respiratory failure. Conclusion In our study, COVID-19 patients had ischemic changes, rate, rhythm abnormalities, and conduction defects in their ECG. With this ongoing pandemic of COVID-19 and limited health resources, ECG—a simple bedside noninvasive tool is highly beneficial and helps in the early diagnosis and management of cardiac injury. How to cite this article Kaliyaperumal D, Bhargavi K, Ramaraju K, Nair KS, Ramalingam S, Alagesan M. Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study. Indian J Crit Care Med 2022;26(1):43–48.
